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Abstract. The rise of antimicrobial resistance for infectious bacteria has become an alarming issue 
to human health. New antimicrobial drugs are in dire need and pivotal to overcome this issue. In this 
study, aspirinate azo ligands bearing different halogens L1-5 has been prepared via diazo-coupling 
reaction. The ligands L1-5 were coordinated with silver, Ag (I) metal to produce Ag(I) aspirin-azo 
complexes C1-5. The antibacterial properties of L1-5 and C1-5 were evaluated against 
Staphylococcus aureus and Escherichia coli using turbidimetric kinetic method. The complexes C1-
5 showed comparable growth inhibition activity towards E. coli (MIC 82-105 ppm) and S. aureus 
(MIC 80-105 ppm) compared to ligands L1-5 with E. coli (MIC 83-200 ppm), S. aureus (80-131 
ppm) and ampicillin (MIC 93 and 124 ppm, respectively). The excellent bacterial resistance of both 
L1-5 and C1-5 indicates the potential of aspirinate azo and their complexes as new antibacterial 
agents, which significantly benefit to the pharmaceutical industries. 
Introduction 
The increase of contagious bacteria has led to the emergence of drug resistance which caused many 
deaths in the society [1]. The development of new drugs with antimicrobial drug resistance properties 
is in dire need to overcome the growth of pathogenic bacteria. Several types of antimicrobial drugs 
have been developed through the manufacture of commercial drugs derived from azo dyes such as 
phenazopyridine [2].    
Several studies have been reported on the synthesis of azo dyes with a wide spectrum of biological 
activity [3]. The azo moieties have the ability to prevent bacteria multiplication and DNA function 
[4, 5].  Organic dyes featuring azo moieties (N=N) in the molecular network have also been widely 
studied due to their thermal and energy storage properties [6, 7, 8].  
Hybridization of azo dyes with natural product-based compounds with multifunctional groups can 
increase the efficiency and probability of additional interactions with biological targets/receptors [3]. 
Our preliminary studies on azo dyes bearing natural product-based compounds such as aspirin and 
kojic acid showed antibacterial activities [3, 8, 9, 10] and anticancer activity [11, 12].   
Complexation of azo dyes with heavy metals namely Ag(I) can also increase the cytotoxic and 
antibacterial properties [13]. The formation of chelation between a metal ion and ligand able to 
improve the biological activities compared to the ligands alone [14]. Complexation is able to increase 
the lipophilicity of ligands, which allow the ligand to enter the bacterial cell and interact with the 
enzyme receptor or DNA [13]. Ag metal is well known for its antimicrobial properties [15, 16,17]. 
Ag is non-toxic to humans and has been utilized as antimicrobial agents due to its ability to interact 
with protein and enzyme of bacteria, which eventually leads to bacterial cell death [18, 19, 20]. 
In this paper, the synthesis of natural product-based compounds namely aspirinate azo ligands L1-
5 bearing halogens (F, Cl, Br, I) were synthesized via diazotization and coupling reaction. The 
complexes C1-5 were prepared via complexation with Ag(I) in dark condition and at room 
temperature. The ability of the ligands and complexes to inhibit the growth of S. aureus and E. coli 
were tested using turbidimetric kinetic method. 
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Experimental 
Materials and instrumentational 
Chemicals and solvents were used as received from Merck. The analysis of melting point was 
performed using open capillary method on Stuart SMP3.  Smart Omni Transmission Nicolet IS10 
Perkin Elmers Thermoscientific was used to analyze FTIR spectra. 1H and 13C NMR spectra were 
obtained from JEOL ECA with 1H at 500 MHz and 13C at 125 MHz using standard reference, DMSO-
d6. The elemental CHNS was analyzed using Thermo-Flash (EA 1112) CHN Analyser. The 
transmittance values were analyzed on Optima SP-300. 
Synthesis of halogenated aspirin-azo ligands (L1-5) 
Sodium nitrite (1M, 2mL) was poured into a solution of aniline derivatives (5 mmol) and 
hydrochloric acid (8 M, 8 mL) in an ice bath. Acetylsalicylic acid (5 mmol) and sodium hydroxide  
(1 M, 10.0 mL) were added and continue stirring for 45 min.  Hydrochloric acid (3 mL, 8 M) was 
added dropwise onto the solution mixture until the precipitate formed. The solid was filtered, rinsed, 
recrystallized from hot ethanol and dried under vacuum to obtain the final product L1-5.   
Complexation of Ag (I) complexes [Ag(Aspirin-azo)]NO3 (C1-5) 
Silver nitrate (1 mmol) was added dropwise into aspirin-azo ligands L1-5 (0.5 mmol) in methanol. 
The mixture of silver nitrate and ligand was stirred for 3 h in the dark at room temperature. Solid 
precipitates formed were filtered and washed with water followed methanol and dried to afford the 
final product C1-5.  
Antibacterial study 
Antibacterial studies of the synthesized aspirinate azo ligand L1-5 and Ag(I) complexes C1-5 were 
carried out against E. coli (ATCC 25922) and other common types of bacteria, S. aureus (S48/81).  
Both bacteria sub-cultures were grown in Luria-Bertani (LB) broth at 37 °C.10 mL of LB broth was 
added with ligands and complexes at different concentrations separately (50, 80 and 100 ppm). The 
media and tested compounds were added with 0.2 mL of sub-cultured bacteria. The mixture was then 
stirred and incubated at 37 °C. Dimethyl sulfoxide and ampicillin were set as controls, negative and 
positive, respectively. The transmittance (T) values were recorded for every 1 h (0h – 6h) at 
wavelength 560 nm.  The T values were extrapolated to colony-forming units / mL and articulated in 
ln Nt2.  
Results and Discussion 
Synthesis 
Aspirinate azo ligands L1-5 were initially synthesized via diazotization of halogenated anilines 
derivatives followed by coupling with acetylsalicylic acid with yields 24-85 %. Ag(I) complexes C1-
5 were prepared satisfactorily from direct reaction of L1-5 with silver nitrate in a molar ratio of 1:2 
(Ag: ligand) to produce 26-68 % yields, where azo was acted as nitrogen chelator1. The equivalent 
ratio of Ag(I) and azo ligand gave similar composition and equivalent yields. The synthetic pathway 
of aspirinate azo ligands L1-5 and Ag(I) complexes C1-5 is shown in Scheme 1. The structural 






Scheme 1. The synthetic pathway of halogenated azo-aspirin L1-5 and Ag (I) azo-aspirin complex 
C1-5. 
Based on CHN analysis, the data obtained for L1-5 and C1-5 corresponded to the proposed 
structure of the ligands and complex, [Ag (Aspirin-azo)]NO3. The key functional group present in the 
IR spectra L1-5 and C1-5 is depicted in Table 1. The IR spectra of L1-5 showed a broad band in the 
region 1437–1487 cm−1, which attributed to the v(N=N) [3]. The peaks presence at 1619-1688 cm-1 
and 1660–1676 cm-1 were attributed to v(C=O) vibration, while the appearance of peaks at 1561–
1591 cm-1 was attributed to v(Ar) stretching.  Upon coordination of azo ligands with silver(I) ions, 
the FTIR peaks of C1-5 were significantly shifted indicates successful coordination to produce new 
silver(I) aspirinate azo compounds. All the absorption peaks attributed to v(C=O), v(Ar) and v(N=N) 
in C1-5 were shifted to a higher frequency [21, 22].  
The significance resonance of 1H and 13C NMR corresponded to the L1-5 and C1-5 structure is 
shown in Table 2 and Table 3. The coordination of Ag(I) complex C1-5 is shown in Fig. 1.  
The coordination of Ag(I) with aspirinate azo ligands L1-5 was confirmed by the shifted of peaks 
in the spectra. The peaks corresponded to H6 in L1-5 were assigned as a doublet at δ 8.30 -8.33 ppm 
and H4 as doublet to doublet at δ 7.92-8.07 ppm, which strongly indicated on the successful coupling 
reaction via the formation of N=N at the para position of OH group. Upon coordination with Ag(I) 
ions, H4 was shifted to the upfield at δ 0.06-0.21 ppm. While H2’ was shifted upfield at δ 0.01- 
0.10 ppm.  The shift of 1H peaks was also contributed by the existence of nitrate ions (NO3
-) in the 
complexes. The nitrate ions worked as a counter ion and established a small or minor interaction with 
an aromatic proton [23].   
The 13C NMR spectra of L1-5 and C1-5 were in agreement with the target structures as indicated 
by the occurrence of resonances at δ 148.5-152.2 ppm and δ 142.7-144.4 ppm attributed to C1’ and 
C5, respectively. Upon coordination with Ag(I) ions, C5 has shifted upfield in the range of δ 0.82-
1.58 ppm. While C1’ was shifted downfield in the range of δ 0.21-0.49 ppm (Table 3). Ag(I) was 
envisaged to coordinate with N bonded to C5 due to the strong shifting effect [24, 25]. 
Table 1. Summary of main FTIR band of azo ligand L1-5 and Ag(I) complex C1-5. 
Compound Wavelength (cm−1) 
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Table 2. Summary of 1H NMR resonances nearest to the N=N moieties. 
Compound 1H NMR shifts in ppm 













































Shift value (ppm) 0.162 0.080 0.103 
 
Table 3. The resonances of 13C NMR for L1-5 and C1-5. 




































Shift value (ppm) 0.487 1.584 
 
 





Aspirinate azo ligands L1-5 and Ag(I) aspirinate azo complexes C1-5 showed antimicrobial 
properties screened on bacteria S. aureus and E. coli at the various concentration [26]. In both 
bacteria, MIC values were obtained by inducing the growth rate concentration to zero for both bacteria 
as shown in Table 4. 
 
Table 4. MIC values of L1-5 and C1-5 for E. coli and S. aureus. 































Ampicillin 93 124 
 
Ligands L1, L3-L5 demonstrated good antibacterial activities with MIC values 83-117 ppm and 
70-104 ppm against E. coli and S. aureus ppm respectively, which are comparable to ampicillin (MIC 
93 ppm and 124 ppm, respectively). Aspirinate azo dyes L5 bearing iodine exhibited excellent 
inhibition against E. coli with MIC 83 ppm, while L4 bearing bromine showed excellent growth 
inhibition against S. aureus with MIC 70 ppm. The presence of azo moieties in the ligands has 
contributed to the strong inhibition of bacteria growth [27, 28]. Additionally, the presence of hydroxyl 
(OH) and carboxyl group (COOH) in the molecular network has contributed to the hydrophilic 
properties of the molecules which allowed the ligand to interact with bacteria receptors or DNA via 
hydrogen bonds interaction. The halogen in the ligand has contributed to the increase of antimicrobial 
activity.  Moreover, the halogen has the capability to upsurge the lipophilicity of ligand for facile 
diffusion into the bacterial cell wall and membrane via the interaction of halogen bond towards 
bacterial receptor or DNA [29, 30, 31]. 
The formation of Ag(I) complexes, however, showed the increase and decrease in the 
antimicrobial activities (Table 4). The complexes (C1-5) gave comparable and lower MIC values of 
82-105 ppm and 72-131 ppm against E. coli and S. aureus, respectively compared to ampicillin (MIC 
93 ppm and 124 ppm, respectively) and the ligands L1-5.  While the complexes (C1-2) demonstrated 
a stronger ability to inhibit the growth of E. coli with MIC 82 ppm and 105 ppm, respectively 
compared to their free ligands L1 (117 ppm) and L2 (>200 ppm). While the growth inhibition activity 
against S. aureus demonstrated compound C3 and C5 with excellent MIC values of 80ppm and  
72 ppm, respectively, in comparison to their ligands L3 (MIC 98 ppm) and L5 (MIC 80 ppm).  
Upon coordination with Ag, the antibacterial activity was increased as the lipophilicity of the 
compound increased [31]. Furthermore, Ag(I) ions have also improved the π-electrons delocalization 
throughout the ligand molecule, thus increase its ability to penetrate the lipid cell membrane of the 
bacteria [32, 33]. The decrease in the inhibition activities is believed due to the high lipophilic 
properties of the complexes after coordinated with Ag that reduced the solubility of complexes to 
dissolve and react with enzyme and protein [34]. It can be concluded that the combined interaction 
of hydrophilicity and lipophilicity of a molecule plays an essential part in the antibacterial properties 
of the compounds [3, 32]. 
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Conclusion 
Aspirinate azo derivatives bearing series of halogens L1-5 were successfully synthesized and 
coordinated with Ag to form complexes C1-5. The azo derivatives L4 gave excellent inhibition 
against S. aureus (MIC 70 ppm) while complex C1 showed excellent inhibition against E. coli 
featuring the lowest MIC value (MIC 82 ppm) as compared to other ligands, complexes and standard 
ampicillin antibiotic drug. The presence of halogens in L2-5 exhibited excellent antimicrobial 
activities compared to L1.  Coordination of ligands with Ag(I) has increased the lipophilicity of the 
overall complexes and increased the antibacterial activity.  C3-5 had a marginal decrease in activity 
for growth inhibition against E. coli as compared to the ligands. The excellent antibacterial properties 
of aspirinate azo dyes and Ag coordination have shown promising potential for the development of 
new antibiotic drugs in the pharmaceutical industry. 
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